Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
about
Gene-environment interaction and risk of breast cancerEvaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersFine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.IGFBP-2 and -5: important regulators of normal and neoplastic mammary gland physiologyBreast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerPolymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionAn intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expressionFunctional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskInteraction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women.Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue.Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray ExperimentsDownregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cellsGermline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerFive endometrial cancer risk loci identified through genome-wide association analysis.A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 BindingThe genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression.Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities.A functional variant rs4442975 modulating FOXA1-binding affinity does not influence the risk or progression of breast cancer in Chinese Han population.Endometriosis risk alleles at 1p36.12 act through inverse regulation of CDC42 and LINC00339.Strategies for fine-mapping complex traits.Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.Functional dissection of breast cancer risk-associated TERT promoter variants.Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants.Association analysis identifies 65 new breast cancer risk loci.Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Common Genetic Variation and Breast Cancer Risk - Past, present, and future.Association study confirms two susceptibility loci for breast cancer in Chinese Han women.ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.Capture Hi-C identifies putative target genes at 33 breast cancer risk loci.Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses
P2860
Q26772236-9229A68D-946C-4B23-A18B-5FF6DCA15F75Q33614244-F319543E-1784-4A69-A3BA-723009811FE7Q34903062-E4DE9B27-3A5A-4ADC-8D5F-A18917EB1C46Q35690638-CAA429B7-9FA2-4145-A8D6-10673A4CCCAFQ35940158-B0DF7F30-BBDC-4952-BB10-C5EE2B0724CFQ36026731-2E6DD360-F589-4838-A157-95EAAA173836Q36066735-E23ECFD1-AD64-4211-BF10-61A69F70BDE7Q36073563-1488BB25-0B90-4241-A090-82149BC1F03BQ36124728-0650DA8A-3D8C-45CD-9BD3-20D184AC323BQ36248936-357A8075-EA55-4918-A989-6FE66D948E73Q36249029-79612FD0-4971-4D1A-9505-0643A70A27CBQ36267818-3079F1E6-A410-484B-A82A-BE8020567C3EQ36356727-21A8BDAC-18DA-423C-8D0C-82C7992B9B3EQ36401144-46BBCCFE-BDBF-4918-B706-DCD68EB47134Q36719626-3FC801DE-CB80-46CE-A9A9-ED699340AD63Q36916243-C8F64738-1397-483B-AEE5-83FE8AAD05F5Q37002930-532E8912-34AC-47E5-AC2D-5BC337EF7B3EQ37005064-961F922C-3C23-430A-A947-84124EB72099Q37156403-3B715EFF-A904-4A6C-B446-2BBB8E31420CQ37342144-31D9EAD2-0E3F-49D6-9CFA-AA11690696C5Q37396372-A4A87A50-44E8-4EE9-91EF-370A7F061231Q37697205-568341F6-803C-418E-AAA5-7322B2E20260Q38402820-C4ACFECF-3054-4745-BF5A-E73C50D128CCQ38544247-AEB10D32-009E-4A75-93F9-C88573216E11Q38640565-376C0699-DDA8-4EE9-A47A-DA1042917863Q38794059-0BE3FC94-A778-4C04-983E-9D2A3F067561Q38997020-82256ACF-15F1-41F3-BEA7-3D52070C6737Q40137431-1083A822-43EE-462D-B972-83AE988D05CEQ40346126-E5C4AD81-05C5-4894-A6E8-AD332EBB9634Q42366538-C2F58C31-FEF7-4ADE-971E-8E8954F62B8FQ43247768-E5C8CB52-A427-4851-AF37-A03E551E6A1AQ45979098-FFCB3088-6F41-4390-A2D7-1C26C77CE6CEQ46103372-C9FAC118-BC27-43C6-AC6E-FD236932E8EAQ47703662-8E0989D3-451B-4933-B58A-BCF6B206950EQ48013761-BDDC462C-9760-4B5E-83AE-F15E48BE5B74Q53699376-E07A2E6D-B82F-4DC5-9BF9-BBB5FF4DF441Q55064805-EF1838B9-465F-4967-92AE-6BBE45BF31A0Q57108215-2732514B-EEC0-4809-B0D3-8C198881B1D4
P2860
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@ast
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@en
type
label
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@ast
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@en
prefLabel
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@ast
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@en
P2093
P2860
P50
P356
P1476
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
@en
P2093
Australian Ovarian Cancer Management Group
Bernardo Bonanni
Carolien H M van Deurzen
Caroline Baynes
Catherine S Healey
Catriona McLean
Cheng Har Yip
Chiu-Chen Tseng
Christi J Van Asperen
P2860
P2888
P356
10.1038/NCOMMS5999
P407
P50
P577
2014-09-23T00:00:00Z